| Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets BA Nacev, F Sanchez-Vega, SA Smith, CR Antonescu, E Rosenbaum, ... Nature Communications 13 (1), 3405, 2022 | 135 | 2022 |
| Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape M Golkaram, F Kuo, S Gupta, MI Carlo, ML Salmans, R Vijayaraghavan, ... Genome Medicine 14 (1), 143, 2022 | 36 | 2022 |
| A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation E Benedetti, EM Liu, C Tang, F Kuo, M Buyukozkan, T Park, J Park, ... Nature Metabolism 5 (6), 1029-1044, 2023 | 27 | 2023 |
| Genomic and metabolic hallmarks of SDH-and FH-deficient renal cell carcinomas A Yoo, C Tang, M Zucker, K Fitzgerald, RG DiNatale, PM Rappold, ... European urology focus 8 (5), 1278-1288, 2022 | 20 | 2022 |
| A single session of aerobic exercise mediates plasticity-related phosphorylation in both the rat motor cortex and hippocampus JS Thacker, Y Xu, C Tang, AR Tupling, WR Staines, JG Mielke Neuroscience 412, 160-174, 2019 | 13 | 2019 |
| Immunometabolic coevolution defines unique microenvironmental niches in ccRCC C Tang, AX Xie, EM Liu, F Kuo, M Kim, RG DiNatale, M Golkaram, ... Cell Metabolism 35 (8), 1424-1440. e5, 2023 | 11 | 2023 |
| Single-cell mtDNA dynamics in tumors is driven by coregulation of nuclear and mitochondrial genomes M Kim, AN Gorelick, I Vàzquez-García, MJ Williams, S Salehi, H Shi, ... Nature Genetics, 1-11, 2024 | 6 | 2024 |
| A multimodal atlas of tumor metabolism reveals the architecture of gene-metabolite co-regulation E Benedetti, EM Liu, C Tang, F Kuo, M Buyukozkan, T Park, J Park, ... bioRxiv, 2022.11. 23.517549, 2022 | 3 | 2022 |
| Obesity-dependent selection of driver mutations in cancer C Tang, VJ Castillon, M Waters, C Fong, T Park, S Boscenco, S Kim, ... Nature Genetics, 1-4, 2024 | 2 | 2024 |
| Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma L Eismann, AX Xie, C Tang, A Knezevic, I Ostrovnaya, F Kuo, AA Hakimi, ... European Urology 87 (1), 79-83, 2025 | 1 | 2025 |
| Obesity shapes selection for driver mutations in cancer C Tang, VJ Castillon, M Waters, C Fong, T Park, S Boscenco, S Kim, ... medRxiv, 2024 | 1 | 2024 |
| The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs T Grubb, J Khatun, S Matar, F Ghandour, N Dubasik, C Salem, ... bioRxiv, 2023.09. 04.556240, 2023 | 1 | 2023 |
| Functional and translational consequences of immunometabolic coevolution in ccRCC. E Reznik, C Tang, A Xie, EM Liu, F Kuo, M Kim, M Golkaram, Y Chen, ... Oncologist 28, 2023 | 1 | 2023 |
| PD18-01 GENOMIC CHARACTERIZATION OF RECURRENT URCC TUMORS JSA Villada, LP Calderon, C Tang, L Eismann, M Zucker, SW Reese, ... Journal of Urology 211 (5S), e432, 2024 | | 2024 |
| PD51-12 COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE … S Reese, V Yarlagadda, CY Wu, F Kuo, C Tang, H Jiang, M Dawidek, ... The Journal of Urology 211 (5S), e1071, 2024 | | 2024 |
| Non canonical mitochondrial hotspot mutations in cancer S Boscenco, J Tait-Mulder, M Kim, C Tang, M Zucker, T Park, W Wei, ... Cancer Research 84 (6_Supplement), 4341-4341, 2024 | | 2024 |
| COMPREHENSIVE IMMUNOGENOMIC EVALUATION OF PATIENTS UNDERGOING CONSOLIDATIVE CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT … S Reese, V Yarlagadda, CY Wu, F Kuo, C Tang, H Jiang, LH Vuong, ... Urologic Oncology: Seminars and Original Investigations 42, S44, 2024 | | 2024 |
| Microenvironmental Determinants of Metabolic Heterogeneity in Cancer C Tang Weill Medical College of Cornell University, 2023 | | 2023 |
| Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets. BA Nacev, F Sanchez-Vega, S Smith, C Antonescu, E Rosenbaum, H Shi, ... CLINICAL CANCER RESEARCH 28 (18), 9-10, 2022 | | 2022 |
| Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic … BA Nacev, F Sanchez-Vega, S Smith, C Antonescu, E Rosenbaum, H Shi, ... Clinical Cancer Research 28 (18_Supplement), PR012-PR012, 2022 | | 2022 |
